Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 565 drug PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


drug PhD Projects, Programmes & Scholarships

We have 565 drug PhD Projects, Programmes & Scholarships

Precision Medicine DTP - Genetic colocalisation across disease to identify drug repurposing candidates and risk of patient co-morbidities

  Research Group: Centre for Inflammation Research
Background. Discoverying new drugs is expensive, time intensive and fraught with failure at all stages (1). An attractive alternative, with much lower costs and faster development timelines, is to find new applications for already approved drugs, a process known as drug repurposing or drug reallocation. Read more

Precision Medicine DTP - AI-driven drug discovery for diseases of unmet need with high-throughput phenomics data

Abstract. Drug discovery is extremely expensive and most candidate compounds fail at various stages of clinical trials. Artificial Intelligence (AI) has recently emerged as a promising tool to accelerate the search for new active compounds. Read more

Enzyme-responsive peptide hydrogels as in situ forming long-acting drug delivery implants

One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more

Integrative data analysis: from novel biomarker-drug response associations to predicting effective drug combinations

  Research Group: Translational Tumour Biology
More than 140 children with cancer die in Australia each year due to the occurrence of resistance to traditional chemotherapy. To improve overall survival rates for high-risk paediatric cancer patients, the Children’s Cancer Institute initiated the Zero Childhood Cancer national personalised medicine trial (PRISM). Read more

Investigating the Mechanisms of Drug Response to Novel Anti-Cancer Therapies

Repurposing drug screens with compounds that have already gained FDA approval can accelerate the identification of new therapies to treat an illness and in the cancer setting extend life or provide compassionate care. Read more

Mechanistic design of effective pharmaceutical cocrystal formulations

It is estimated that more than 70 percent of the compounds in the pharmaceutical pipeline can be poorly water-soluble. Since solid drug forms must dissolve before absorption can occur, strategies to improve drug solubility and dissolution are a continuous need. Read more

Mathematical modelling for preclinical drug trials: small molecule drugs and antibody drug conjugates

Preclinical evaluation of drug efficacy plays a fundamental role in the development of cancer treatments. Mathematical modelling is fundamental to these preclinical studies, specifically to describe the tumour dynamics and evaluate the anti-tumour effect. Read more

Discovering off-target side-effects and drug repurposing candidates using expression perturbation data

Rationale. Mendelian Randomization (MR) is a genetic epidemiology method which utilises variants sourced from genome-wide association studies (GWAS) to assess causality between risk/protective factors and disease outcomes in a manner less biased to observational studies(1). Read more

Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer

  Research Group: Institute of Cancer Therapeutics
Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working. Read more

Filtering Results